Scientists Engineer Parasite to Deliver Brain Therapies

Researchers modify Toxoplasma gondii to transport proteins across the blood-brain barrier, showing promise for neurological treatments.

Toxoplasma gondii, a common brain-invading parasite, has been genetically modified to carry therapeutic proteins.
The engineered parasite successfully delivered proteins in lab-grown human brain models and live mice.
This method could overcome the challenge of transporting drugs through the blood-brain barrier.
Further development is needed to ensure the parasite's safety for human use.
The research offers a potential new approach for treating neurological disorders.